• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PROMIS-Preference 评分系统的横断面验证。

Cross-sectional validation of the PROMIS-Preference scoring system.

机构信息

Department of General Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.

Department of Engineering and Public Policy and Institute for Politics and Strategy, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.

出版信息

PLoS One. 2018 Jul 31;13(7):e0201093. doi: 10.1371/journal.pone.0201093. eCollection 2018.

DOI:10.1371/journal.pone.0201093
PMID:30063733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6067708/
Abstract

OBJECTIVES

The PROMIS-Preference (PROPr) score is a recently developed summary score for the Patient-Reported Outcomes Measurement Information System (PROMIS). PROPr is a preference-based scoring system for seven PROMIS domains created using multiplicative multi-attribute utility theory. It serves as a generic, societal, preference-based summary scoring system of health-related quality of life. This manuscript evaluates construct validity of PROPr in two large samples from the US general population.

METHODS

We utilized 2 online panel surveys, the PROPr Estimation Survey and the Profiles-Health Utilities Index (HUI) Survey. Both included the PROPr measure, patient demographic information, self-reported chronic conditions, and other preference-based summary scores: the EuroQol-5D (EQ-5D-5L) and HUI in the PROPr Estimation Survey and the HUI in the Profiles-HUI Survey. The HUI was scored as both the Mark 2 and the Mark 3. Known-groups validity was evaluated using age- and gender-stratified mean scores and health condition impact estimates. Condition impact estimates were created using ordinary least squares regression in which a summary score was regressed on age, gender, and a single health condition. The coefficient for the health condition is the estimated effect on the preference score of having a condition vs. not having it. Convergent validity was evaluated using Pearson correlations between PROPr and other summary scores.

RESULTS

The sample consisted of 983 respondents from the PROPr Estimation Survey and 3,000 from the Profiles-HUI survey. Age- and gender-stratified mean PROPr scores were lower than EQ-5D and HUI scores, with fewer subjects having scores corresponding to perfect health on the PROPr. In the PROPr Estimation survey, all 11 condition impact estimates were statistically significant using PROPr, 8 were statistically significant by the EQ-5D, 7 were statistically significant by HUI Mark 2, and 9 were statistically significant by HUI Mark 3. In the Profiles-HUI survey, all 21 condition impact estimates were statistically significant using summary scores from all three scoring systems. In these samples, the correlations between PROPr and the other summary measures ranged from 0.67 to 0.70.

CONCLUSIONS

These results provide evidence of construct validity for PROPr using samples from the US general population.

摘要

目的

PROMIS-偏好(PROPr)评分是一种新开发的患者报告结果测量信息系统(PROMIS)综合评分。PROPr 是一种基于乘法多属性效用理论的七个 PROMIS 领域的偏好评分系统。它是一种通用的、基于社会的、基于偏好的健康相关生活质量综合评分系统。本文利用来自美国普通人群的两个大型样本评估了 PROPr 的结构效度。

方法

我们利用了 2 个在线面板调查,即 PROPr 估计调查和概况-健康效用指数(HUI)调查。这两个调查都包含了 PROPr 量表、患者人口统计学信息、自我报告的慢性疾病和其他偏好综合评分:欧洲五维健康量表(EQ-5D-5L)和 HUI 在 PROPr 估计调查中,HUI 在概况-HUI 调查中。HUI 分别被评为 Mark 2 和 Mark 3。采用年龄和性别分层均值评分和健康状况影响估计值来评估已知组别的有效性。通过普通最小二乘回归,将综合评分与年龄、性别和单一健康状况进行回归,从而创建状况影响估计值。健康状况的系数是存在健康状况与不存在健康状况对偏好评分的估计影响。采用 PROPr 与其他综合评分之间的 Pearson 相关来评估聚合效度。

结果

样本包括来自 PROPr 估计调查的 983 名受访者和来自概况-HUI 调查的 3000 名受访者。年龄和性别分层的 PROPr 评分低于 EQ-5D 和 HUI 评分,较少的受试者的 PROPr 评分对应于完全健康。在 PROPr 估计调查中,所有 11 个状况影响估计值使用 PROPr 均具有统计学意义,8 个使用 EQ-5D 具有统计学意义,7 个使用 HUI Mark 2 具有统计学意义,9 个使用 HUI Mark 3 具有统计学意义。在概况-HUI 调查中,使用来自所有三个评分系统的综合评分,所有 21 个状况影响估计值均具有统计学意义。在这些样本中,PROPr 与其他综合测量指标之间的相关性范围为 0.67 至 0.70。

结论

这些结果提供了使用来自美国普通人群的样本对 PROPr 的结构有效性的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/680217477c5a/pone.0201093.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/bbe4598ad658/pone.0201093.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/e89cdae559a0/pone.0201093.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/83c3156141e9/pone.0201093.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/977f84691c78/pone.0201093.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/43d9532be018/pone.0201093.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/680217477c5a/pone.0201093.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/bbe4598ad658/pone.0201093.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/e89cdae559a0/pone.0201093.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/83c3156141e9/pone.0201093.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/977f84691c78/pone.0201093.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/43d9532be018/pone.0201093.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca3b/6067708/680217477c5a/pone.0201093.g006.jpg

相似文献

1
Cross-sectional validation of the PROMIS-Preference scoring system.PROMIS-Preference 评分系统的横断面验证。
PLoS One. 2018 Jul 31;13(7):e0201093. doi: 10.1371/journal.pone.0201093. eCollection 2018.
2
Cross-sectional validation of the PROMIS-Preference scoring system by its association with social determinants of health.通过与健康的社会决定因素的关联,对 PROMIS-Preference 评分系统进行横断面验证。
Qual Life Res. 2021 Mar;30(3):881-889. doi: 10.1007/s11136-020-02691-3. Epub 2020 Nov 8.
3
Comparison of the EQ-5D-5L and the patient-reported outcomes measurement information system preference score (PROPr) in the United States.美国 EQ-5D-5L 与患者报告结局测量信息系统偏好评分(PROPr)的比较。
J Patient Rep Outcomes. 2024 Jul 19;8(1):76. doi: 10.1186/s41687-024-00749-1.
4
Utilities Estimated from PROMIS Scales for Cost-Effectiveness Analyses in Stroke.基于 PROMIS 量表的脑卒中成本效益分析效用值估算。
Med Decis Making. 2023 Aug;43(6):704-718. doi: 10.1177/0272989X231182446. Epub 2023 Jul 4.
5
A Direct Comparison of the Measurement Properties of EQ-5D-5L, PROMIS-29+2 and PROMIS Global Health Instruments and EQ-5D-5L and PROPr Utilities in a General Population Sample.在一般人群样本中,EQ-5D-5L、PROMIS-29+2 和 PROMIS 全球健康量表与 EQ-5D-5L 和 PROPr 效用工具的测量特性直接比较。
Value Health. 2023 Jul;26(7):1045-1056. doi: 10.1016/j.jval.2023.02.002. Epub 2023 Feb 17.
6
Comparison of the PROMIS Preference Score (PROPr) and EQ-5D-5L Index Value in General Population Samples in the United Kingdom, France, and Germany.英国、法国和德国普通人群样本中 PROMIS 偏好评分(PROPr)与 EQ-5D-5L 指数值的比较。
Value Health. 2022 May;25(5):824-834. doi: 10.1016/j.jval.2021.10.012. Epub 2021 Dec 15.
7
Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary.匈牙利EQ-5D-5L、PROPr和SF-6D的人群常模。
Pharmacoeconomics. 2024 May;42(5):583-603. doi: 10.1007/s40273-024-01360-4. Epub 2024 Feb 28.
8
Evaluation of PROMIS Preference Scoring System (PROPr) in Patients Undergoing Hemodialysis or Kidney Transplant.评估接受血液透析或肾移植患者的 PROMIS 偏好评分系统(PROPr)。
Clin J Am Soc Nephrol. 2021 Sep;16(9):1328-1336. doi: 10.2215/CJN.01880221. Epub 2021 Jul 16.
9
Estimation of a Preference-Based Summary Score for the Patient-Reported Outcomes Measurement Information System: The PROMIS-Preference (PROPr) Scoring System.患者报告结局测量信息系统(PROMIS)偏好评分系统:基于偏好的总结评分估算。
Med Decis Making. 2018 Aug;38(6):683-698. doi: 10.1177/0272989X18776637. Epub 2018 Jun 26.
10
Psychometric properties of the PROMIS Preference score (PROPr) in patients with rheumatological and psychosomatic conditions.风湿性和身心疾病患者中PROMIS偏好评分(PROPr)的心理测量特性。
BMC Rheumatol. 2022 Mar 7;6(1):15. doi: 10.1186/s41927-022-00245-3.

引用本文的文献

1
Patient-Reported Outcomes Among an Observational Cohort of Individuals With Chronic Low Back Pain.慢性下腰痛患者观察队列中的患者报告结局
JOR Spine. 2025 Aug 13;8(3):e70097. doi: 10.1002/jsp2.70097. eCollection 2025 Sep.
2
Childhood cigarette smoking is associated with health-related quality of life in older US adults.美国老年人童年时期吸烟与健康相关生活质量有关。
Tob Induc Dis. 2025 Jul 23;23. doi: 10.18332/tid/204009. eCollection 2025.
3
Mapping and Linking between the EQ-5D-5L and the PROMIS Domains in the United States.

本文引用的文献

1
Estimation of a Preference-Based Summary Score for the Patient-Reported Outcomes Measurement Information System: The PROMIS-Preference (PROPr) Scoring System.患者报告结局测量信息系统(PROMIS)偏好评分系统:基于偏好的总结评分估算。
Med Decis Making. 2018 Aug;38(6):683-698. doi: 10.1177/0272989X18776637. Epub 2018 Jun 26.
2
Evaluation of options for presenting health-states from PROMIS® item banks for valuation exercises.评估 PROMIS® 项目库中呈现健康状态的选项,用于估值练习。
Qual Life Res. 2018 Jul;27(7):1835-1843. doi: 10.1007/s11136-018-1852-1. Epub 2018 Apr 12.
3
Selection of key health domains from PROMIS for a generic preference-based scoring system.
美国EQ-5D-5L与患者报告结果测量信息系统(PROMIS)领域之间的映射与关联
Med Decis Making. 2025 Aug;45(6):740-752. doi: 10.1177/0272989X251340990. Epub 2025 Jun 13.
4
The Role of Patient-Reported Outcomes in Cirrhosis.患者报告结局在肝硬化中的作用。
Am J Gastroenterol. 2025 May 20;120(8):1708-1719. doi: 10.14309/ajg.0000000000003551.
5
Health economic evaluation of trans-tibial prosthetic suspension systems: a protocol for a pilot using an observational study and synthetic cohort.经胫骨假肢悬吊系统的卫生经济评估:一项使用观察性研究和合成队列的试点研究方案
Cost Eff Resour Alloc. 2025 Apr 12;23(1):15. doi: 10.1186/s12962-025-00611-1.
6
Comparing Analgesic Regimen Effectiveness and Safety after Surgery (CARES): protocol for a pragmatic, international multicentre randomised trial.比较手术后镇痛方案的有效性和安全性(CARES):一项实用的国际多中心随机试验方案
BMJ Open. 2025 Apr 5;15(4):e099925. doi: 10.1136/bmjopen-2025-099925.
7
Comparative- and Cost-Effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women With HIV to Full Viral Suppression (Text Me, Alexis!): Protocol for a Randomized Controlled Trial.比较与成本效益研究:确定促进感染艾滋病毒的跨性别女性实现完全病毒抑制的最佳干预措施(给我发短信,亚历克西斯!):一项随机对照试验的方案
JMIR Res Protoc. 2025 Jan 23;14:e65313. doi: 10.2196/65313.
8
Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD).优化阿片类物质使用障碍药物治疗的留存策略:CTN-0100试验(随机数字拨号法)的留存阶段
Contemp Clin Trials. 2025 Mar;150:107816. doi: 10.1016/j.cct.2025.107816. Epub 2025 Jan 20.
9
Protocol for a randomized controlled trial with a stepped care approach, utilizing PrEP navigation with and without contingency management, for transgender women and sexual minority men with a substance use disorder: Assistance Services Knowledge-PrEP (A.S.K.-PrEP).一项随机对照试验的方案,采用递进式护理方法,为有物质使用障碍的跨性别女性和性少数男性提供 PrEP 导航,同时使用和不使用意外管理:援助服务知识-PreP(A.S.K.-PreP)。
Addict Sci Clin Pract. 2024 Nov 9;19(1):79. doi: 10.1186/s13722-024-00482-6.
10
Agreement of PROMIS Preference (PROPr) scores generated from the PROMIS-29 + 2 and the PROMIS-16.由PROMIS-29 + 2和PROMIS-16生成的PROMIS偏好(PROPr)评分的一致性。
Qual Life Res. 2025 Jan;34(1):43-51. doi: 10.1007/s11136-024-03827-5. Epub 2024 Nov 7.
从患者报告结果测量信息系统(PROMIS)中选择关键健康领域,用于构建一个基于偏好的通用评分系统。
Qual Life Res. 2017 Dec;26(12):3377-3385. doi: 10.1007/s11136-017-1686-2. Epub 2017 Aug 19.
4
Update to the Report of Nationally Representative Values for the Noninstitutionalized US Adult Population for Five Health-Related Quality-of-Life Scores.美国非机构化成年人口五项健康相关生活质量评分全国代表性值报告的更新
Value Health. 2016 Dec;19(8):1059-1062. doi: 10.1016/j.jval.2016.05.019. Epub 2016 Aug 21.
5
Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.在一项具有全国代表性的横断面调查中,健康状况影响因基于偏好的健康指数而有很大差异。
Med Decis Making. 2016 Feb;36(2):264-74. doi: 10.1177/0272989X15599546. Epub 2015 Aug 27.
6
The PROMIS of QALYs.质量调整生命年的患者报告结果测量信息系统(PROMIS)
Health Qual Life Outcomes. 2015 Aug 11;13:122. doi: 10.1186/s12955-015-0321-6.
7
Agreement about identifying patients who change over time: cautionary results in cataract and heart failure patients.关于识别随时间变化的患者的一致性:白内障和心力衰竭患者的警示结果。
Med Decis Making. 2012 Mar-Apr;32(2):273-86. doi: 10.1177/0272989X11418671. Epub 2011 Oct 18.
8
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).新的 EQ-5D 五维版本(EQ-5D-5L)的制定和初步测试。
Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
9
The use of PROMIS and assessment center to deliver patient-reported outcome measures in clinical research.在临床研究中使用患者报告结局测量信息系统(PROMIS)和评估中心来提供患者报告的结局指标。
J Appl Meas. 2010;11(3):304-14.
10
Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel.患者报告结局测量信息系统互联网面板的代表性。
J Clin Epidemiol. 2010 Nov;63(11):1169-78. doi: 10.1016/j.jclinepi.2009.11.021. Epub 2010 Aug 5.